-Search query
-Search result
Showing all 44 items for (author: silacci-fregni & c)
EMDB-29530:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-29531:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-40240:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8fxb:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8fxc:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8s9g:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-28558:
SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-28559:
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8erq:
SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8err:
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-12890:
Tetanus neurotoxin HC domain in complex with TT104-Fab1
Method: single particle / : Grinzato A, Kandiah E, Zanotti G
EMDB-12891:
Tetanus neurotoxin LC-HN domain in complex with TT110-Fab1
Method: single particle / : Grinzato A, Kandiah E, Zanotti G
PDB-7oh0:
Tetanus neurotoxin HC domain in complex with TT104-Fab1
Method: single particle / : Grinzato A, Kandiah E, Zanotti G
PDB-7oh1:
Tetanus neurotoxin LC-HN domain in complex with TT110-Fab1
Method: single particle / : Grinzato A, Kandiah E, Zanotti G
EMDB-24533:
SARS-CoV-2 spike protein bound to the S2P6 and S2M11 Fab fragments
Method: single particle / : Sauer MM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-24299:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24300:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Veesler D
EMDB-24301:
SARS-CoV-2 spike glycoprotein ectodomain in complex with the S2H97 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Veesler D
PDB-7r7n:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24236:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24237:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
Method: single particle / : McCallum M, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-7n8h:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7n8i:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
Method: single particle / : McCallum M, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-22879:
cryoEM structure of LILRB1 D3D4 domain-inserted antibody MDB1 Fab in complex with Plasmodium RIFIN (PF3D7_1373400) V2 domain
Method: single particle / : Xu K, Kwong PD
PDB-7khf:
CryoEM structure of LILRB1 D3D4 domain-inserted antibody MDB1 Fab in complex with Plasmodium RIFIN (PF3D7_1373400) V2 domain
Method: single particle / : Xu K, Kwong PD
EMDB-22491:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22492:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Snell G, Veesler D
EMDB-22494:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22497:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Snell G, Veesler D
EMDB-22506:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22507:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22508:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (three receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22512:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Snell G, Veesler D
EMDB-22516:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22517:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv2:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv4:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv6:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jva:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jvc:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jw0:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-9135:
Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174
Method: single particle / : Acharya P, Stewart-Jones G, Carragher B, Potter CS, Kwong PD
PDB-6mjz:
Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174
Method: single particle / : Acharya P, Stewart-Jones G, Carragher B, Potter CS, Kwong PD
EMDB-3391:
Negative-stain electron microscopy structure of human cytomegalovirus gHgLgO trimer
Method: single particle / : Kabanova A, Marcandalli J, Zhou T, Bianchi S, Baxa U, Tsybovsky Y, Lilleri D, Silacci-Fregni C, Foglierini M, Fernandez-Rodriguez BM, Druz A, Zhang B, Geiger R, Pagani M, Sallusto F, Kwong PD, Corti D, Lanzavecchia A, Perez L